Lei Zhao

机构：Thomas Jefferson University, Sun Yat-sen University, Chinese Academy of Medical Sciences & Peking Union Medical College, Sichuan University, Southwest Medical University, West China Hospital of Sichuan University, Southeast University, Sidney Kimmel Cancer Center, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, First Hospital of China Medical University, Sun Yat-sen University Cancer Center, Third People's Hospital of Hefei, Hefei First People's Hospital, Southeast University, China Medical University · ORCID：0000-0003-0926-0944

发表论文 68 篇 · 总被引 1159 次 · h-index 16

代表论文

• MiR-218-5p/EGFR Signaling in Arsenic-Induced Carcinogenesis (2023 · Cancers · 被引 16)
• Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial (2025 · The Lancet Oncology · 被引 12)
• LncRNA SLC9A3-AS1 knockdown increases the sensitivity of liver cancer cell to triptolide by regulating miR-449b-5p-mediated glycolysis (2023 · Biotechnology and Genetic Engineering Reviews · 被引 9)
• Identification of an m6A Natural Inhibitor, Lobeline, That Reverses Lenvatinib Resistance in Hepatocellular Tumors (2024 · Journal of Natural Products · 被引 8)
• Identification of the Immune Subtypes for the Prediction of Metastasis in Pancreatic Neuroendocrine Tumors (2023 · Neuroendocrinology · 被引 8)
• Gut-to-tumor translocation of multidrug-resistant Klebsiella pneumoniae shapes the microbiome and chemoresistance in pancreatic cancer (2025 · Frontiers in Cellular and Infection Microbiology · 被引 6)